University Children´s Hospital III Essen

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Vyxeos® With Clofarabine for Pediatric AML	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence	Recruiting	Phase 1	2025-09-05		NCT07156435

Clinical trials